FIELD: chemistry.
SUBSTANCE: invention relates to a novel biologically active compound such as a peptide which enables production of an antibody which selectively detects the oligomeric form of nucleophosmin protein in preparations containing monomeric or oligomeric protein forms.
EFFECT: invention can be efficiently used to produce an immunodiagnostic preparation for investigating and monitoring cancerous growths.
1 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE WITH PROTECTIVE ACTION AGAINST ALZHEIMER'S DISEASE | 2008 |
|
RU2372355C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES HAVING EFFECT ON SURVIVIN IN TUMOUR TISSUE | 2009 |
|
RU2396277C1 |
| PEPTIDE STIMULATING FORMATION OF SPECIFIC ANTIBODIES AGAINST MONOMERIC FORM OF NUCLEOPHOSMIN IN TUMOUR CELLS | 2009 |
|
RU2401274C1 |
| PEPTIDE HAVING CURATIVE EFFECT AGAINST ALZHEIMER DISEASE | 2014 |
|
RU2558242C1 |
| PEPTIDE HAVING THERAPEUTIC EFFECT AGAINST ALZHEIMER'S DISEASE | 2018 |
|
RU2677296C2 |
| PEPTIDE WITH TREATMENT ACTION AGAINST ALZHEIMER'S DISEASE | 2016 |
|
RU2626972C2 |
| GLP-1 PEPTIDE HAVING ATTACHED OLIGOSACCHARIDE CHAIN | 2008 |
|
RU2539829C2 |
| METASTIN DERIVATIVES AND USE THEREOF | 2007 |
|
RU2454425C2 |
| METASTIN DERIVATIVES AND APPLICATION THEREOF | 2006 |
|
RU2430107C2 |
| GLYCATED PEPTIDE GLP-1 | 2009 |
|
RU2543157C2 |
